| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/09/2011 | CN101966312A Chinese medicinal composition for treating chronic renal failure and preparation method thereof |
| 02/09/2011 | CN101966308A Chinaroot greenbrier extract for treating chronic prostatitis and preparation method thereof |
| 02/09/2011 | CN101966278A Traditional Chinese medicine for treating urinary tract infection and preparation method thereof |
| 02/09/2011 | CN101966257A Traditional Chinese medicine for treating chronic prostatitis |
| 02/09/2011 | CN101966148A Injection composition comprising coenzyme Q10 and preparation method thereof |
| 02/09/2011 | CN101965974A Compositions and products containing enantiomeric equol, and methods for their making |
| 02/09/2011 | CN101422546B Functional food for treating male prostatitis |
| 02/09/2011 | CN101406667B Liquid medicine for relieving middle and discharging calculi |
| 02/09/2011 | CN101288753B Chinese medicinal composition for treating S hematuria and preparation method and quality control method thereof |
| 02/09/2011 | CN101254260B Pharmaceutical combination for curing prostate gland hyperplasy, anuresis and preparation thereof |
| 02/09/2011 | CN101020044B Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
| 02/08/2011 | US7883719 Pasting agent |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2403475C Device and method for treating urinary incontinence in females |
| 02/08/2011 | CA2370466C Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/03/2011 | WO2011013644A1 Substituted piperidine compound |
| 02/03/2011 | WO2011013624A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | WO2011013623A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | US20110028531 Novel sirna compounds for inhibiting rtp801 |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028493 Heterocyclic derivative and use thereof |
| 02/03/2011 | US20110028490 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake in-hibitors |
| 02/03/2011 | US20110028481 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028463 Amide compounds |
| 02/03/2011 | US20110028461 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028437 Phosphorylated pyrone analogs and methods |
| 02/03/2011 | US20110028413 Methods of Reducing Methotrexate Nephrotoxicity |
| 02/03/2011 | US20110028398 Methods for treating and limiting fibrotic disorders and keloids |
| 02/03/2011 | US20110028394 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | US20110028388 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 02/03/2011 | US20110027362 Tablet having improved elution properties |
| 02/03/2011 | US20110027305 Composition Comprising an Extract of Herbal Combination Thereof for Preventing and Treating Diabetes Mellitus |
| 02/03/2011 | US20110027215 Protein-based polymer tissue adhesives for medical use |
| 02/03/2011 | CA2768816A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768814A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2279029A2 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN101965337A Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
| 02/02/2011 | CN101965187A Crystalline micropowder particles |
| 02/02/2011 | CN101962384A Chromene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 02/02/2011 | CN101962323A 2-acrylyl X radical-3-substituted phenyl propionate compound and purpose thereof |
| 02/02/2011 | CN101961497A Inhibition of Syk kinase expression |
| 02/02/2011 | CN101961493A Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 02/02/2011 | CN101961451A Kidney-tonifying and body-strengthening oral liquid |
| 02/02/2011 | CN101961421A Traditional Chinese medicine for treating diabetic nephropathy |
| 02/02/2011 | CN101961420A Traditional Chinese medicine for treating diabetic nephropathy |
| 02/02/2011 | CN101961416A Traditional Chinese medicine for treating chronic prostatitis |
| 02/02/2011 | CN101961407A Traditional Chinese medicine for treating prostatic hyperplasia |
| 02/02/2011 | CN101961390A Traditional Chinese medicine pills for treating stranguria caused by heat-evil |
| 02/02/2011 | CN101961366A Preparation method of malan straw extract, malan straw product, pharmaceutical composition and application thereof |
| 02/02/2011 | CN101961323A Self-emulsified resveratrol soft capsules |
| 02/02/2011 | CN101468029B Difructose anhydride-containing composition and use thereof |
| 02/02/2011 | CN101361763B Pollen hormone freeze dehydration method |
| 02/02/2011 | CN101306091B Use of prince feather and fleabane combination in preparing medicament for treating kidney disease |
| 02/02/2011 | CN101259256B Chinese medicine for treating infantile enuresis |
| 02/02/2011 | CN101088510B Use of Cordycepic polysaccharide in pharmacy |
| 02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/01/2011 | US7879881 Piperidinyl compounds that selectively bind integrins |
| 02/01/2011 | US7879874 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2464689C Modified release tamsulosin tablets |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2442414C Use of rare earth compounds for the prevention of kidney stone disease |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2408685C Liquid pharmaceutical composition containing an erythropoietin derivate |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/27/2011 | WO2011011753A1 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | WO2011010691A1 Polyion complex comprising phd2 expression inhibiting substance |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021597 3-phenoxymethylpyrrolidine compounds |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | US20110021542 Use of a Combination of Udenafil and Alfuzosin or Oxybutynin for the Treatment of Overactive Bladder |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 01/27/2011 | US20110021499 Urethral suppositories for overactive bladder |
| 01/27/2011 | US20110021480 17-beta HSD1 and STS Inhibitors |
| 01/27/2011 | US20110021448 Inhibitors for the Soluble Epoxide Hydrolase |
| 01/27/2011 | US20110021432 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | US20110021429 Renoprotection by growth hormone-releasing hormone and agonists |
| 01/27/2011 | US20110020338 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
| 01/27/2011 | US20110020328 Antibody formulations |
| 01/27/2011 | US20110020326 Method of treating polycystic kidney disease |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277910A1 Albumin fusion proteins |
| 01/26/2011 | EP2277889A2 Fusion proteins of albumin and interferon beta |
| 01/26/2011 | EP2277888A2 Fusion proteins of albumin and erythropoietin |
| 01/26/2011 | EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 01/26/2011 | EP2277877A1 Quinazoline derivatives as kinase inhibitors |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277874A1 Activator for peroxisome proliferator-activated receptor |